IS6733A - Fjölsykrur með virkni gegn blóðtappa, sem samanstanda af, að minnsta kosti, samgildu tengi við bíótín eða bíótínafleiðu - Google Patents
Fjölsykrur með virkni gegn blóðtappa, sem samanstanda af, að minnsta kosti, samgildu tengi við bíótín eða bíótínafleiðuInfo
- Publication number
- IS6733A IS6733A IS6733A IS6733A IS6733A IS 6733 A IS6733 A IS 6733A IS 6733 A IS6733 A IS 6733A IS 6733 A IS6733 A IS 6733A IS 6733 A IS6733 A IS 6733A
- Authority
- IS
- Iceland
- Prior art keywords
- biotin
- polysaccharides
- clotting activity
- covalent link
- activity consisting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0012094A FR2814463B1 (fr) | 2000-09-22 | 2000-09-22 | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
PCT/FR2001/002918 WO2002024754A1 (fr) | 2000-09-22 | 2001-09-20 | Polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
Publications (2)
Publication Number | Publication Date |
---|---|
IS6733A true IS6733A (is) | 2003-02-28 |
IS2550B IS2550B (is) | 2009-10-15 |
Family
ID=8854579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS6733A IS2550B (is) | 2000-09-22 | 2003-02-28 | Fjölsykrur með virkni gegn blóðtappa, sem samanstanda af, að minnsta kosti, samgildu tengi við bíótín eða bíótínafleiðu |
Country Status (40)
Country | Link |
---|---|
US (3) | US6844329B2 (is) |
EP (1) | EP1322673B1 (is) |
JP (2) | JP5016778B2 (is) |
KR (2) | KR20080049139A (is) |
CN (1) | CN1235914C (is) |
AR (1) | AR030774A1 (is) |
AT (1) | ATE374215T1 (is) |
AU (2) | AU9196001A (is) |
BG (1) | BG66191B1 (is) |
BR (1) | BR0114007A (is) |
CA (1) | CA2418815C (is) |
CY (1) | CY1108076T1 (is) |
CZ (1) | CZ300856B6 (is) |
DE (1) | DE60130669T2 (is) |
DK (1) | DK1322673T3 (is) |
EA (1) | EA005133B1 (is) |
EC (1) | ECSP034514A (is) |
EE (1) | EE05202B1 (is) |
ES (1) | ES2292625T3 (is) |
FR (1) | FR2814463B1 (is) |
GE (1) | GEP20053616B (is) |
HK (1) | HK1053316A1 (is) |
HR (1) | HRP20030219B1 (is) |
HU (2) | HUP0303551A3 (is) |
IL (2) | IL154848A0 (is) |
IS (1) | IS2550B (is) |
ME (2) | ME00080B (is) |
MX (1) | MXPA03002483A (is) |
NO (2) | NO332905B1 (is) |
NZ (1) | NZ524472A (is) |
PE (1) | PE20020471A1 (is) |
PL (1) | PL206727B1 (is) |
PT (1) | PT1322673E (is) |
RS (1) | RS50730B (is) |
SI (1) | SI1322673T1 (is) |
SK (2) | SK287218B6 (is) |
TW (1) | TWI308153B (is) |
UA (1) | UA79736C2 (is) |
WO (1) | WO2002024754A1 (is) |
ZA (1) | ZA200301692B (is) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
FR2874924B1 (fr) * | 2004-09-09 | 2006-12-01 | Sanofi Aventis Sa | Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique |
TWI403334B (zh) * | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
TWI376234B (en) * | 2005-02-01 | 2012-11-11 | Msd Oss Bv | Conjugates of a polypeptide and an oligosaccharide |
NZ567221A (en) * | 2005-10-10 | 2010-06-25 | Organon Nv | Anticoagulant antithrombotic dual inhibitors comprising a biotin label |
UA94593C2 (ru) * | 2005-10-10 | 2011-05-25 | Н.В. Органон | Антитромбозные двойные ингибиторы с биотиновой меткой |
CN1317035C (zh) * | 2005-10-24 | 2007-05-23 | 天津大学 | 基于酰肼基的微粒表面多重生物功能因子组装方法 |
EP1886696A1 (en) * | 2006-08-03 | 2008-02-13 | Endotis Pharma | Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins |
FR2912409B1 (fr) * | 2007-02-14 | 2012-08-24 | Sanofi Aventis | Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation |
EP2233143A1 (en) | 2009-03-24 | 2010-09-29 | Sanofi-Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
EP2145624A1 (en) | 2008-07-18 | 2010-01-20 | Sanofi-Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
TW201006479A (en) * | 2008-07-18 | 2010-02-16 | Sanofi Aventis | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
FR2935386B1 (fr) | 2008-08-26 | 2010-09-10 | Sanofi Aventis | Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine |
CA2735983A1 (en) * | 2008-09-10 | 2010-03-18 | Transpharma Medical Ltd. | Transdermal delivery of oligosaccharides |
JP5783908B2 (ja) | 2008-12-19 | 2015-09-24 | スパーナス ファーマシューティカルズ インコーポレイテッド | 攻撃性を治療する方法 |
FR2952935B1 (fr) * | 2009-11-20 | 2011-12-02 | Sanofi Aventis | Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle |
JP6109574B2 (ja) | 2009-12-18 | 2017-04-05 | カタラン、フランス、バインハイム、ソシエテ、アノニムCatalent France Beinheim Sa | 合成オリゴサッカリドを含有する医薬経口剤形 |
CZ302510B6 (cs) * | 2010-03-29 | 2011-06-22 | Univerzita Palackého v Olomouci | Efektivní zpusob biotinylace sloucenin s karboxylovou skupinou pomocí syntézy na pevné fázi pro potreby afinitní chromatografie |
CZ302669B6 (cs) * | 2010-03-29 | 2011-08-24 | Univerzita Palackého v Olomouci | Efektivní zpusob biotinylace aminosloucenin pomocí syntézy na pevné fázi pro potreby afinitní chromatografie |
WO2011123497A1 (en) | 2010-03-31 | 2011-10-06 | Supernus Pharmaceuticals Inc. | Stabilized formulations of cns compounds |
EP2614089A1 (fr) | 2010-09-10 | 2013-07-17 | Sanofi-Aventis | Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree |
FR2964660B1 (fr) * | 2010-09-10 | 2012-09-28 | Sanofi Aventis | Nouveaux polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree |
EP2484366A1 (en) | 2011-02-07 | 2012-08-08 | Sanofi | Idrabiotaparinux for the treatment of pulmonary embolism and for the secondary prevention of venous thromboembolic events |
EP2721044B1 (en) | 2011-06-17 | 2015-11-18 | Carbomimetics | Synthetic pentasaccharides having short half-life and high activity |
US20140135326A1 (en) * | 2012-11-13 | 2014-05-15 | Supernus Pharmaceuticals, Inc. | Method of treatment of aggression |
WO2015195404A1 (en) | 2014-06-20 | 2015-12-23 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for detection of an analyte by movement of tethered microparticles |
WO2016205239A1 (en) | 2015-06-15 | 2016-12-22 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein |
CA3041059C (en) | 2016-10-21 | 2023-09-26 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Molecular nanotags |
CN108976318B (zh) * | 2017-06-01 | 2021-03-30 | 首都医科大学 | 单-6-(生物素酰胺基)-6-脱氧-β-环糊精及其制备方法和应用 |
WO2019133727A1 (en) | 2017-12-29 | 2019-07-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Universal influenza virus probe set for enrichment of any influenza virus nucleic acid |
EP3997238A1 (en) | 2019-07-09 | 2022-05-18 | Optimvia, LLC | Methods for synthesizing anticoagulant polysaccharides |
WO2021075165A1 (ja) * | 2019-10-17 | 2021-04-22 | 株式会社オートネットワーク技術研究所 | 配線モジュール |
WO2022056078A1 (en) | 2020-09-11 | 2022-03-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rnase h-assisted detection assay for rna (radar) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3960884A (en) * | 1974-04-24 | 1976-06-01 | Sergei Ivanovich Zavyalov | Method of preparing racemic biotin |
AU563351C (en) * | 1982-01-15 | 2003-06-19 | Glaxo Group Limited | Synthesis of oligosaccharides |
IL102758A (en) * | 1991-08-23 | 1997-03-18 | Akzo Nv | Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them |
US20010023288A1 (en) * | 1999-07-07 | 2001-09-20 | Wilbur D. Scott | Trifunctional reagent for conjugation to a biomolecule |
WO2000002050A1 (en) * | 1998-07-07 | 2000-01-13 | Department Of Radiation Oncology, University Of Washington | Trifunctional reagent for conjugation to a biomolecule |
FR2751334B1 (fr) * | 1996-07-19 | 1998-10-16 | Sanofi Sa | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant |
FR2773801B1 (fr) * | 1998-01-19 | 2000-05-12 | Sanofi Sa | Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant |
FR2773804B1 (fr) * | 1998-01-19 | 2000-02-18 | Sanofi Sa | Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant |
GB2335490B (en) * | 1998-03-20 | 2003-05-14 | Ortho Clinical Diagnostics | An assay surface that permits an analyte releasiing step |
US6492503B1 (en) | 1998-07-31 | 2002-12-10 | Seikagaku Corporation | Glycosaminoglycan and drug compositions containing the same |
FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
-
2000
- 2000-09-22 FR FR0012094A patent/FR2814463B1/fr not_active Expired - Fee Related
-
2001
- 2001-09-20 RS YUP-197/03A patent/RS50730B/sr unknown
- 2001-09-20 UA UA2003021719A patent/UA79736C2/uk unknown
- 2001-09-20 HU HU0303551A patent/HUP0303551A3/hu not_active Application Discontinuation
- 2001-09-20 AU AU9196001A patent/AU9196001A/xx active Pending
- 2001-09-20 BR BR0114007-8A patent/BR0114007A/pt active Search and Examination
- 2001-09-20 ME MEP-2008-236A patent/ME00080B/me unknown
- 2001-09-20 ES ES01972171T patent/ES2292625T3/es not_active Expired - Lifetime
- 2001-09-20 EA EA200300237A patent/EA005133B1/ru not_active IP Right Cessation
- 2001-09-20 CN CNB018161588A patent/CN1235914C/zh not_active Expired - Fee Related
- 2001-09-20 EP EP01972171A patent/EP1322673B1/fr not_active Expired - Lifetime
- 2001-09-20 AU AU2001291960A patent/AU2001291960C1/en not_active Ceased
- 2001-09-20 KR KR1020087009747A patent/KR20080049139A/ko not_active Application Discontinuation
- 2001-09-20 GE GE5103A patent/GEP20053616B/en unknown
- 2001-09-20 US US10/381,154 patent/US6844329B2/en not_active Expired - Lifetime
- 2001-09-20 DE DE60130669T patent/DE60130669T2/de not_active Expired - Lifetime
- 2001-09-20 KR KR1020037004108A patent/KR100891388B1/ko not_active IP Right Cessation
- 2001-09-20 SK SK5031-2009A patent/SK287218B6/sk not_active IP Right Cessation
- 2001-09-20 CA CA2418815A patent/CA2418815C/en not_active Expired - Fee Related
- 2001-09-20 ME MEP-236/08A patent/MEP23608A/xx unknown
- 2001-09-20 WO PCT/FR2001/002918 patent/WO2002024754A1/fr active Application Filing
- 2001-09-20 JP JP2002529162A patent/JP5016778B2/ja not_active Expired - Fee Related
- 2001-09-20 IL IL15484801A patent/IL154848A0/xx unknown
- 2001-09-20 DK DK01972171T patent/DK1322673T3/da active
- 2001-09-20 EE EEP200300114A patent/EE05202B1/xx not_active IP Right Cessation
- 2001-09-20 MX MXPA03002483A patent/MXPA03002483A/es active IP Right Grant
- 2001-09-20 AR ARP010104436A patent/AR030774A1/es not_active Application Discontinuation
- 2001-09-20 HU HUP1400034 patent/HU1400034D0/hu not_active Application Discontinuation
- 2001-09-20 PT PT01972171T patent/PT1322673E/pt unknown
- 2001-09-20 NZ NZ524472A patent/NZ524472A/en not_active IP Right Cessation
- 2001-09-20 CZ CZ20030814A patent/CZ300856B6/cs not_active IP Right Cessation
- 2001-09-20 AT AT01972171T patent/ATE374215T1/de active
- 2001-09-20 PL PL363368A patent/PL206727B1/pl unknown
- 2001-09-20 SI SI200130786T patent/SI1322673T1/sl unknown
- 2001-09-20 SK SK356-2003A patent/SK287054B6/sk not_active IP Right Cessation
- 2001-09-21 PE PE2001000952A patent/PE20020471A1/es not_active Application Discontinuation
- 2001-09-21 TW TW090123340A patent/TWI308153B/zh not_active IP Right Cessation
-
2003
- 2003-02-28 IS IS6733A patent/IS2550B/is unknown
- 2003-02-28 ZA ZA200301692A patent/ZA200301692B/en unknown
- 2003-03-10 IL IL154848A patent/IL154848A/en not_active IP Right Cessation
- 2003-03-14 EC EC2003004514A patent/ECSP034514A/es unknown
- 2003-03-20 NO NO20031295A patent/NO332905B1/no not_active IP Right Cessation
- 2003-03-20 BG BG107650A patent/BG66191B1/bg unknown
- 2003-03-21 HR HR20030219A patent/HRP20030219B1/xx not_active IP Right Cessation
- 2003-08-05 HK HK03105615A patent/HK1053316A1/xx not_active IP Right Cessation
-
2005
- 2005-01-14 US US11/035,717 patent/US7943595B2/en not_active Expired - Fee Related
-
2007
- 2007-12-04 CY CY20071101542T patent/CY1108076T1/el unknown
-
2011
- 2011-02-28 US US13/036,143 patent/US8318696B2/en not_active Expired - Fee Related
- 2011-03-16 NO NO20110401A patent/NO20110401L/no not_active Application Discontinuation
-
2012
- 2012-02-10 JP JP2012027377A patent/JP2012131809A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6733A (is) | Fjölsykrur með virkni gegn blóðtappa, sem samanstanda af, að minnsta kosti, samgildu tengi við bíótín eða bíótínafleiðu | |
ITRM20000041A0 (it) | Derivati glicosamminoglicani parzialmente desolfatati non anticoagulanti ad attivita' antiangiogenica. | |
AU2001291960A1 (en) | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | |
DE60111161D1 (de) | Stent mit geringem Querschnitt | |
DE60014149D1 (de) | Modularer, endoluminaler stent mit angepassten steifigkeitszonen | |
NO20013814L (no) | Nede i hullet traktor | |
DE60032758D1 (de) | Intraluminale auskleidung | |
DK1056723T3 (da) | 2-pyridylmethylaminderivater, der er egnede som fungicider | |
PT1177185E (pt) | Derivados de 4, 5, 6, 7-tetra-hidroindazole como agentes antitumorais | |
DE60019922D1 (de) | Bioresorbierbarer stent | |
DK1115479T3 (da) | Hurtigt petidiserbare, mikrokrystallinske, cellulosebaserede stabiliseringsmidler | |
BR9902938B1 (pt) | composiÇÕes baseadas em dissulfeto de dimetila com um cheiro mascarado. | |
EE00297U1 (et) | Kaubakapp | |
DE60035257D1 (de) | Mehrachsige turbine | |
DE10083638D2 (de) | Laschenkette | |
NO20055002D0 (no) | Benzol[1,2,5]tiadiazolforbindelser | |
NO20022689L (no) | Antitrombotisk forbindelse | |
NO20032088D0 (no) | Installasjon for dyppebelegging av et metallbånd | |
DE10082233D2 (de) | Bauelement, bestehend aus einer Unterlegscheibe mit einem Mittelloch | |
ATE505459T1 (de) | Dibenzoäb,füazepin-derivate und ihre herstellung | |
IS6285A (is) | Setnar N-fenýl 2-hýdroxý-2-metýl-3,3,3-tríflúorprópamíð afleiður sem auka pýruvat vetnissviftis virkni | |
IT250120Y1 (it) | Collegamento a polsino | |
IS5930A (is) | Hýgrómýsín A afleiður sem bakteríueyðandi miðlar | |
DE60021924D1 (de) | Polysaccharide mit immunostimulierender aktivität | |
SE0002502D0 (sv) | The pharmacological use of a certain disulfide derivative |